pyquvi

Generic: deflazacort

Labeler: aucta pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pyquvi
Generic Name deflazacort
Labeler aucta pharmaceuticals, inc.
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

deflazacort 22.75 mg/mL

Manufacturer
Aucta Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 73289-0089
Product ID 73289-0089_39853cd7-c033-848f-e063-6294a90a49e4
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA219417
Listing Expiration 2026-12-31
Marketing Start 2025-06-30

Pharmacologic Class

Established (EPC)
corticosteroid [epc]
Mechanism of Action
corticosteroid hormone receptor agonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 732890089
Hyphenated Format 73289-0089

Supplemental Identifiers

RxCUI
1870964 2719198
UNII
KR5YZ6AE4B
NUI
N0000175576 N0000175450

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pyquvi (source: ndc)
Generic Name deflazacort (source: ndc)
Application Number ANDA219417 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 22.75 mg/mL
source: ndc
Packaging
  • 13 mL in 1 BOTTLE (73289-0089-1)
source: ndc

Packages (1)

73289-0089-1 13 mL in 1 BOTTLE (73289-0089-1)

Ingredients (1)

deflazacort (22.75 mg/mL)

Linked Drug Pages (1)

PYQUVI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "39853cd7-c033-848f-e063-6294a90a49e4", "openfda": {"nui": ["N0000175576", "N0000175450"], "unii": ["KR5YZ6AE4B"], "rxcui": ["1870964", "2719198"], "spl_set_id": ["39854f19-d8be-6438-e063-6394a90a9422"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "manufacturer_name": ["Aucta Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "13 mL in 1 BOTTLE (73289-0089-1)", "package_ndc": "73289-0089-1", "marketing_start_date": "20250630"}], "brand_name": "PYQUVI", "product_id": "73289-0089_39853cd7-c033-848f-e063-6294a90a49e4", "dosage_form": "SUSPENSION", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "73289-0089", "generic_name": "deflazacort", "labeler_name": "Aucta Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PYQUVI", "active_ingredients": [{"name": "DEFLAZACORT", "strength": "22.75 mg/mL"}], "application_number": "ANDA219417", "marketing_category": "ANDA", "marketing_start_date": "20250630", "listing_expiration_date": "20261231"}